The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
MicroRNA-451 Is Involved in the Self-renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells
Abstract
Many antitumor therapies affect rapidly dividing cells. However, tumor proliferation may be driven by cancer stem cells (CSCs), which divide slowly and are relatively resistant to cytotoxic drugs. Thus, many tumors may progress because CSCs are not sensitive to the treatment. In this work, we searched for target genes whose expression is involved in proliferation and chemoresistance of CSCs. Both of these processes could be controlled simultaneously by cell regulators such as microRNAs (miRNAs). Therefore, colonospheres with properties of CSCs were obtained from different colon carcinoma cells, and miRNA profiling was performed. The results showed that miR-451 was downregulated in colonspheres versus parental cells. Surprisingly, expression of miR-451 caused a decrease in self-renewal, tumorigenicity, and chemoresistance to irinotecan of colonspheres. We identified cyclooxygenase-2 (COX-2) as an indirect miR-451 target gene involved in sphere growth. Our results indicate that miR-451 downregulation allows the expression of the direct target gene macrophage migration inhibitory factor, involved in the expression of COX-2. In turn, COX-2 allows Wnt activation, which is essential for CSC growth. Furthermore, miR-451 restoration decreases expression of the ATP-binding cassette drug transporter ABCB1 and results in irinotecan sensitization. These findings correlate well with the lower expression of miR-451 observed in patients who did not respond to irinotecan-based first-line therapy compared with patients who did. Our data suggest that miR-451 is a novel candidate to circumvent recurrence and drug resistance in colorectal cancer and could be used as a marker to predict response to irinotecan in patients with colon carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
MicroRNAs in cell proliferation, cell death, and tumorigenesis
Hwang, H.-W., & Mendell, J. T. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603023 · Cited by 1,399
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
Calin, G. A., Liu, C.-G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C. D., Shimizu, M., Cimmino, A., Zupo, S., Dono, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404432101 · Cited by 1,285
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 689
Kovalchuk, O., Filkowski, J., Meservy, J., Ilnytskyy, Y., Tryndyak, V. P., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 635
Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., & Bucala, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012511599 · Cited by 622
Dallas, N. A., Xia, L., Fan, F., Gray, M. J., Gaur, P., van Buren, G., Samuel, S., Kim, M. P., Lim, S. J., & Ellis, L. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2023 · Cited by 572
Zhu, H., Wu, H., Liu, X., Evans, B. R., Medina, D. J., Liu, C.-G., & Yang, J.-M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.007 · Cited by 456
MicroRNA-451 Regulates LKB1/AMPK Signaling and Allows Adaptation to Metabolic Stress in Glioma Cells
Godlewski, J., Nowicki, M. O., Bronisz, A., Nuovo, G., Palatini, J., De Lay, M., Van Brocklyn, J., Ostrowski, M. C., Chiocca, E. A., & Lawler, S. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.018 · Cited by 419
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
Song, B., Wang, Y., Xi, Y., Kudo, K., Bruheim, S., Botchkina, G. I., Gavin, E., Wan, Y., Formentini, A., Kornmann, M., et al. (2009) · Oncogene · doi:10.1038/onc.2009.274 · Cited by 410
Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas
Hui, A. B. Y., Lenarduzzi, M., Krushel, T., Waldron, L., Pintilie, M., Shi, W., Perez-Ordonez, B., Jurisica, I., O'Sullivan, B., Waldron, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2166 · Cited by 397
Bandres, E., Bitarte, N., Arias, F., Agorreta, J., Fortes, P., Agirre, X., Zarate, R., Diaz-Gonzalez, J. A., Ramirez, N., Sola, J. J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1818 · Cited by 346
Self-citationWang, R., Wang, Z.-X., Yang, J.-S., Pan, X., De, W., & Chen, L.-B. (2011) · Oncogene · doi:10.1038/onc.2010.642 · Cited by 297
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells
Gal, H., Pandi, G., Kanner, A. A., Ram, Z., Lithwick-Yanai, G., Amariglio, N., Rechavi, G., & Givol, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.107 · Cited by 234
Choi, D., Lee, H. W., Hur, K. Y., Kim, J. J., Park, G.-S., Jang, S.-H., Song, Y. S., Jang, K.-S., & Paik, S. S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2258 · Cited by 203
Targeting Wnt Signaling in Colon Cancer Stem Cells
de Sousa, E. M. F., Vermeulen, L., Richel, D., & Medema, J. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1204 · Cited by 203
Human Colon Cancer Stem Cells: A New Paradigm in Gastrointestinal Oncology
Boman, B. M., & Huang, E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.6941 · Cited by 200
miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2
Pase, L., Layton, J. E., Kloosterman, W. P., Carradice, D., Waterhouse, P. M., & Lieschke, G. J. (2009) · Blood · doi:10.1182/blood-2008-05-155812 · Cited by 196
Somatodendritic microRNAs identified by laser capture and multiplex RT-PCR
Kye, M.-J., Liu, T., Levy, S. F., Xu, N. L., Groves, B. B., Bonneau, R., Lao, K., & Kosik, K. S. (2007) · RNA · doi:10.1261/rna.480407 · Cited by 191
Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis.
Masaki, S., Ohtsuka, R., Abe, Y., Muta, K., & Umemura, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.077 · Cited by 178
MiRNA-451 plays a role as tumor suppressor in human glioma cells
Nan, Y., Han, L., Zhang, A., Wang, G., Jia, Z., Yang, Y., Yue, X., Pu, P., Zhong, Y., & Kang, C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.074 · Cited by 176
Minderman, H., O’Loughlin, K. L., Pendyala, L., & Baer, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0914-3 · Cited by 170
MicroRNA expression dynamics during murine and human erythroid differentiation
Zhan, M., Miller, C. P., Papayannopoulou, T., Stamatoyannopoulos, G., & Song, C.-Z. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.03.014 · Cited by 168
Fang, D. D., Kim, Y. J., Lee, C. N., Aggarwal, S., McKinnon, K. M., Mesmer, D., Norton, J., Birse, C. E., He, T., Ruben, S. M., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605610 · Cited by 154
Carli, C., Metz, C. N., Al‐Abed, Y., Naccache, P. H., & Akoum, A. (2009) · Endocrinology · doi:10.1210/en.2008-1088 · Cited by 110
Isolation and Culture of Colon Cancer Stem Cells
Cammareri, P., Lombardo, Y., Francipane, M. G., Bonventre, S., Todaro, M., & Stassi, G. (2008) · Methods in cell biology · doi:10.1016/s0091-679x(08)00014-9 · Cited by 102
Differentiated Human Colorectal Cancer Cells Protect Tumor-Initiating Cells From Irinotecan
Emmink, B. L., van Houdt, W. J., Vries, R. G. J., Hoogwater, F. J. H., Govaert, K. M., Verheem, A., Nijkamp, M. W., Steller, E. J. A., Jiménez, C. R., Clevers, H. C., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.052 · Cited by 93
Chu, X., Kato, Y., Ueda, K., Suzuki, H., Niinuma, K., Tyson, C. A., Weizer, V., Dabbs, J. E., Froehlich, R., Green, C. E., et al. (1998) · PubMed · Cited by 90
MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line
Zhang, H., Li, W., Nan, F., Ren, F., Wang, H., Xu, Y., & Zhang, F. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.106 · Cited by 78
Colon cancer stem cells: implications for prevention and therapy
Huang, E. H., & Wicha, M. S. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.005 · Cited by 78
Papapetrou, E. P., Korkola, J. E., & Sadelain, M. (2010) · Stem Cells · doi:10.1002/stem.257 · Cited by 73
Tsuchiya, S., Oku, M., Imanaka, Y., Kunimoto, R., Okuno, Y., Terasawa, K., Sato, F., Tsujimoto, G., & Shimizu, K. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp255 · Cited by 68
New therapeutics targeting colon cancer stem cells
Thenappan, A., Li, Y., Shetty, K., Johnson, L. B., Reddy, E. P., & Mishra, L. (2009) · Current Colorectal Cancer Reports · doi:10.1007/s11888-009-0029-2 · Cited by 42
Xin, D., Rendon, B. E., Zhao, M., Winner, M. G., Coleman, A., & Mitchell, R. A. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0101 · Cited by 41
Cited by
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
The role and mechanisms of action of microRNAs in cancer drug resistance
Si, W., Shen, J., Zheng, H., & Fan, W. (2019) · Clinical Epigenetics · doi:10.1186/s13148-018-0587-8 · Cited by 668
The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma
Das, P. K., Islam, F., & Lam, A. K. (2020) · Cells · doi:10.3390/cells9061392 · Cited by 210
Genovese, I., Ilari, A., Assaraf, Y. G., Fazi, F., & Colotti, G. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.003 · Cited by 156
MicroRNAs in the etiology of colorectal cancer: Pathways and clinical implications
Strubberg, A. M., & Madison, B. B. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027441 · Cited by 147
Metadata
- Authors
- Bitarte, N., Bandres, E., Boni, V., Zarate, R., Rodriguez, J., Gonzalez-Huarriz, M., Lopez, I., Javier Sola, J., Alonso, M. M., Fortes, P., & Garcia-Foncillas, J.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-10-25
- Volume
- 29
- Issue
- 11
- Pages
- 1661-1671
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2066633590
- Cited by
- 272
- References
- 37
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
